4-Hydroxyisoleucine: a plant-derived treatment for metabolic syndrome
- PMID: 19337956
4-Hydroxyisoleucine: a plant-derived treatment for metabolic syndrome
Abstract
The plant fenugreek has been used for centuries as a treatment for diabetes. This article presents evidence that the major isomer of 4-hydroxyisoleucine, an atypical branched-chain amino acid derived from fenugreek, is responsible for the effects of this plant on glucose and lipid metabolism. 4-Hydroxyisoleucine was demonstrated to stimulate glucose-dependent insulin secretion by a direct effect on pancreatic islets. In addition to stimulating insulin secretion, 4-hydroxyisoleucine reduced insulin resistance in muscle and/or liver by activating insulin receptor substrate-associated phosphoinositide 3 (PI3) kinase activity. 4-Hydroxyisoleucine also reduced body weight in diet-induced obese mice. The decrease in body weight was associated with a marked decrease in both plasma insulin and glucose levels, both of which are elevated in this animal model. Finally, 4-hydroxyisoleucine decreased elevated plasma triglyceride and total cholesterol levels in a hamster model of diabetes. Based on the beneficial metabolic properties that have been demonstrated, 4-hydroxyisoleucine, a simple, plant-derived amino acid, may represent an attractive new candidate for the treatment of type 2 diabetes, obesity and dyslipidemia, all key components of metabolic syndrome.
Similar articles
-
The effect of fenugreek 4-hydroxyisoleucine on liver function biomarkers and glucose in diabetic and fructose-fed rats.Phytother Res. 2009 Jan;23(1):61-4. doi: 10.1002/ptr.2557. Phytother Res. 2009. PMID: 18680121
-
4-hydroxyisoleucine an unusual amino acid as antidyslipidemic and antihyperglycemic agent.Bioorg Med Chem Lett. 2006 Jan 15;16(2):293-6. doi: 10.1016/j.bmcl.2005.10.003. Epub 2005 Oct 21. Bioorg Med Chem Lett. 2006. PMID: 16246556
-
Non-insulin dependent anti-diabetic activity of (2S, 3R, 4S) 4-hydroxyisoleucine of fenugreek (Trigonella foenum graecum) in streptozotocin-induced type I diabetic rats.Phytomedicine. 2012 May 15;19(7):571-4. doi: 10.1016/j.phymed.2012.01.004. Epub 2012 Mar 6. Phytomedicine. 2012. PMID: 22397995
-
4-Hydroxyisoleucine from Fenugreek (Trigonella foenum-graecum): Effects on Insulin Resistance Associated with Obesity.Molecules. 2016 Nov 22;21(11):1596. doi: 10.3390/molecules21111596. Molecules. 2016. PMID: 27879673 Free PMC article. Review.
-
New and emerging strategies for reducing cardiometabolic risk factors.Pharmacotherapy. 2006 May;26(5 Pt 2):13S-31S; quiz 43S-45S. doi: 10.1592/phco.26.5part2.13S. Pharmacotherapy. 2006. PMID: 16637783 Review.
Cited by
-
Computational pharmacology and computational chemistry of 4-hydroxyisoleucine: Physicochemical, pharmacokinetic, and DFT-based approaches.Front Chem. 2023 Apr 13;11:1145974. doi: 10.3389/fchem.2023.1145974. eCollection 2023. Front Chem. 2023. PMID: 37123881 Free PMC article.
-
Programming adaptive laboratory evolution of 4-hydroxyisoleucine production driven by a lysine biosensor in Corynebacterium glutamicum.AMB Express. 2021 May 8;11(1):66. doi: 10.1186/s13568-021-01227-3. AMB Express. 2021. PMID: 33963930 Free PMC article.
-
The Effects of Hydro-Alcoholic Extract of Fenugreek Seeds on the Lipid Profile and Oxidative Stress in Fructose-Fed Rats.J Obes Metab Syndr. 2020 Sep 30;29(3):198-207. doi: 10.7570/jomes19051. J Obes Metab Syndr. 2020. PMID: 32883888 Free PMC article.
-
Engineered disulfide bonds improve thermostability and activity of L-isoleucine hydroxylase for efficient 4-HIL production in Bacillus subtilis 168.Eng Life Sci. 2019 Oct 9;20(1-2):7-16. doi: 10.1002/elsc.201900090. eCollection 2020 Jan. Eng Life Sci. 2019. PMID: 32625042 Free PMC article.
-
Reconstitution of TCA cycle involving l-isoleucine dioxygenase for hydroxylation of l-isoleucine in Escherichia coli using CRISPR-Cas9.3 Biotech. 2020 Apr;10(4):167. doi: 10.1007/s13205-020-2160-3. Epub 2020 Mar 13. 3 Biotech. 2020. PMID: 32206501 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical